A recent study demonstrated that the stimulation of the cholinergic anti-inflammatory pathway through the administration of GTS-21 protected against AngII-induced hypertension by enhancing autonomic control, suppressing NF-κB activation, and reducing renal fibrosis and the inflammatory response [38]. This evidence concerns the gene NFKB1 and hypertensive disorder.